Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cyclohexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentane SCHEMBL14992004 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1940278 | 1.00 | — | — | |
| Cyclopentane SCHEMBL8240998 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL21855033 | 1.00 | — | — | |
| Cyclopropane SCHEMBL21855054 | 1.00 | — | — | |
| Cyclohexane SCHEMBL6916325 | 1.00 | — | — | |
| Cyclopentane SCHEMBL21855042 | 1.00 | — | — | |
| Cyclopentane SCHEMBL21855058 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL21855075 | 1.00 | — | — | |
| Cyclohexane SCHEMBL5467398 | 1.00 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025015778-A1 | REVERSE OSMOSIS MEMBRANE PREPARATION METHOD AND REVERSE OSMOSIS MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2025-01-23 | — | — | WO | claimed |
| WO-2025015778-A1 | REVERSE OSMOSIS MEMBRANE PREPARATION METHOD AND REVERSE OSMOSIS MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2025-01-23 | — | — | WO | disclosed |
| EP-3279181-B1 | METHOD FOR PRODUCING A MIXTURE OF A POLYMERIZABLE COMPOUND | ZEON CORP (JP) | 2021-08-04 | — | — | EP | disclosed |
| CN-107428672-B | Mixture of polymerizable compounds and method for producing same | 日本瑞翁株式会社 | 2021-05-14 | — | — | CN | disclosed |
| US-10934246-B2 | Mixture of polymerizable compound and method of producing the same | ZEON CORPORATION (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20200148622-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2020-05-14 | — | — | US | disclosed |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | ZEON CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| EP-3279181-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD FOR PRODUCING SAME | Zeon Corporation (JP) | 2018-02-07 | — | — | EP | disclosed |
| EP-2627439-B1 | METHOD FOR SOLUBILIZING CARBOXYLIC ACID-CONTAINING COMPOUND IN HYDROCARBON SOLVENT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| US-9051227-B2 | In-situ method for preparing hydrolyzed acyl halide compound | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-09 | — | — | US | disclosed |
| US-9051417-B2 | Method for solubilizing carboxylic acid-containing compound in hydrocarbon solvent | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-09 | — | — | US | disclosed |
| US-20140264161-A1 | IN-SITU METHOD FOR PREPARING HYDROLYZED ACYL HALIDE COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140264162-A1 | METHOD FOR SOLUBILIZING CARBOXYLIC ACID-CONTAINING COMPOUND IN HYDROCARBON SOLVENT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2731925-A1 | IN-SITU METHOD FOR PREPARING HYDROLYZED ACYL HALIDE COMPOUND | Dow Global Technologies LLC (US) | 2014-05-21 | — | — | EP | disclosed |
| CN-103328088-A | Method for solubilizing carboxylic acid-containing compounds in hydrocarbon solvents | DOW GLOBAL TECHNOLOGIES INC | 2013-09-25 | — | — | CN | disclosed |
| EP-2627439-A1 | METHOD FOR SOLUBILIZING CARBOXYLIC ACID-CONTAINING COMPOUND IN HYDROCARBON SOLVENT | Dow Global Technologies LLC (US) | 2013-08-21 | — | — | EP | disclosed |
| WO-2013048762-A1 | IN-SITU METHOD FOR PREPARING HYDROLYZED ACYL HALIDE COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013048763-A1 | METHOD FOR SOLUBILIZING CARBOXYLIC ACID-CONTAINING COMPOUND IN HYDROCARBON SOLVENT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-04-04 | — | — | WO | disclosed |
| CN-1109127-A | Paper coating composition | SUMITOMO CHEMICAL CO (JP) | 1995-09-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934246-B2 | Mixture of polymerizable compound and method of producing the same | DDT, CA4, DNMT3B | ALDH1A1 2480/4885 |
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | ALDH1A1 2480/4885 |
| US-20140264161-A1 | IN-SITU METHOD FOR PREPARING HYDROLYZED ACYL HALIDE COMPOUND | HDHD5, LIPA, CEL | ALDH1A1 1266/4885 |
| US-20200148622-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | ALDH1A1 2480/4885 |
| US-10577306-B2 | Mixture of polymerizable compound and method of producing the same | DDT, CA4, DNMT3B | ALDH1A1 2480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.